Albany, NY -- (SBWIRE) -- 12/29/2014 -- Hydrocodone bitartrate is often used to relieve severe ongoing pain. It belongs to the narcotic (opiate) analgesic class of drugs. It affects the functioning of the brain by altering how the body responds to pain. Hydrocodone Bitartrate is generally prescribed for oral ingestion as narcotic aanalgesic and antitussive. It is often given in combination with ibuprofen or acetaminophen. The Administrative Controlled Substance Code Number (ACSCN) for hydrocode is 9193. Medical applications where hydrocodone bitartrate is used to relive pain is the largest application for Hydrocodone Bitartrate. The sale of hydrocodone bitartrate is regulated in various countries since there can be chances of substance abuse.

Early buyers will receive 10% customization on reports
http://www.transparencymarketresearch.com/hydrocodone-bitartrate-market.html

The demand for hydrocodone bitartrate for medical applications is expected to witness strong growth in the next few years. Hydrocodone bitartrate use in cough treatment is anticipated to be the major application in the near future. The ingestion of hydrocodone bitartrate can cause several side effects such as dizziness, nausea, lightheadedness, sedation, vomiting and constipation. The sale of hydrocodone bitartrate is regulated in many countries, the sale is banned in countries such as Belgium, France, Germany, Sweden etc. It is classified as List 1 drug under the Opium Law in Netherlands. The sale of hydrocodone bitartrate for medical use is also banned in United Kingdom, where it is listed as a Class A drug under Misuse of Drugs Act 1971. However, weaker formulation of hydrocodone bitartrate is being used as an alternative in various medical applications. In the U.S. hydrocodone bitartrate is subject to annual manufacturing quota. However, hydrocodone bitartrate is not commercially available in its purest form. It is generally sold with a NSAID, antihistamine, acetaminophen, homatropine or expectorant. Overdose of hydrocodone bitartrate include effects such as widened pupils, shallow, slow or stopped breathing, stopped or slowed heartbeat, clammy, cold or blue skin excessive sleepiness. In certain cases over dosage can also have fatal effects. Hydrocodone bitartrate usage in cough syrup in combinations with other chemicals is expected to one of the major applications in the next few years.

In terms of demand North America was the largest consumer of hydrocodone bitartrate followed by Asia Pacific, Europe and Rest of the World. In North America U.S was the largest market for hydrocodone bitartrate followed by Mexico and Canada. This high demand for hydrocodone bitartrate stems from the growing demand for medical treatment applications in this region. The demand for hydrocodone bitartrate is also projected to witness strong growth in Asia Pacific due to non present regulations in this region. The demand for hydrocodone bitartrate is anticipated to witness strong growth in the Asia Pacific countries such as China, India, Indonesia etc. With growing population in these regions the demand for hydrocodone bitartrate is also expected to grow on similar lines. The economic conditions of Brazil, Russia and South Africa are on similar track and hence the demand for hydrocodone bitartrate is also projected to be high in these countries. The sale of hydrocodone bitartrate is banned is several European countries such as Germany, Sweden, France Belgium, United Kingdom etc. It sold under certain regulation in countries like Netherlands.

Some of the major companies operating in the global hydrocodone bitartrate market are Xi'an Jbiotree Industrial Co., Ltd., Ranbaxy Pharmaceuticals Inc., Ausmauco Biotech Co. Ltd. and AbbVie Inc. among others.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

- North America
- Asia Pacific
- Europe
- Rest of the World

This report provides comprehensive analysis of

- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter's five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Reports on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR's experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Inquiry Before Buying @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3765

Latest Upcoming Reports: http://www.transparencymarketresearch.com/upcoming.htm

Contact Us
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.

Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Browse market research blog:
http://pharmaceuticalmarket.wordpress.com/
http://tmrmarkets.blogspot.co.uk